Further investigations revealed that higher TGR5 expression in hepatocytes was markedly associated with elevated levels of liver function markers (alanine aminotransferase [ALT], aspartate aminotransferase [AST], and alkaline phosphatase [ALP]) in MASLD patients (Table1). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.